amiodarone has been researched along with Anomalous Ventricular Excitation Syndrome in 90 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 8.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "It was reported that intravenous amiodarone might induce ventricular fibrillation for acute treatment in patients with atrial fibrillation (AF) and Wolff-Parkinson-White (WPW) syndrome." | 8.02 | The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome. ( Ren, J; Shao, X; Wang, J; Wu, S; Yang, Y; Zhang, H; Zhu, J, 2021) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 7.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "Amiodarone-induced chemical, sterile epididymitis has previously been reported." | 7.69 | Amiodarone-induced epididymitis. Report of 2 cases. ( Hamoud, K; Kaneti, J; Lissmer, L; Smailowitz, Z, 1996) |
| "Amiodarone resulted in a rapid ventricular response to atrial flutter in an infant with Wolff-Parkinson-White syndrome." | 7.68 | Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome. ( Baxendall, M; Benetar, A; Till, JA, 1993) |
| "In a 20-year-old patient with Marfan's syndrome and Wolff-Parkinson-White syndrome, effective amiodarone treatment had to be stopped due to serious hyperthyroidism." | 7.67 | Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome. ( Hazenberg, HJ; Tietge, FC, 1985) |
| "The clinical and electrophysiologic effects of oral amiodarone were evaluated in 10 patients with a history of spontaneous atrial fibrillation and a rapid ventricular response, complicating the Wolff-Parkinson-White syndrome." | 7.67 | Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. ( Feld, GK; Klitzner, T; Nademanee, K; Singh, BN; Stevenson, W; Weiss, J, 1988) |
| "We observed a dangerous increase of ventricular rate following the intravenous administration of amiodarone in a patient with atrial fibrillation and rapid ventricular response associated with the Wolff-Parkinson-White syndrome." | 7.67 | Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. ( Gmeiner, R; Leisch, F; Schützenberger, W, 1987) |
| "In order to control a re-entrant tachycardia in a patient with Wolff-Parkinson-White syndrome, intravenous Amiodarone (5 mg/Kg per min." | 7.67 | [Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Wolff-Parkinson-White syndrome]. ( Auricchio, A; De Stefano, R; Vitale, P, 1986) |
| "Oral amiodarone was administered to ten children aged 3 months to 15 years who had recurrent SVT associated with the Wolff-Parkinson-White syndrome." | 7.66 | Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. ( Barzilay, Z; Feigl, A; Frand, M; Shahar, E, 1983) |
| "Oral amiodarone has been used to treat 21 patients with various supraventricular arrhythmias; 13 had Wolff-Parkinson-White syndrome, which was complicated by atrial fibrillation and re-entry atrioventricular tachycardia in four, and re-entry tachycardia alone in the other nine." | 7.66 | Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. ( Krikler, DM; Rowland, E, 1980) |
| "In patients with the Wolff-Parkinson-White syndrome, intravenous ajmaline (50 mg administered over 3 minutes) or procainamide (10 mg/kg body weight administered over 10 minutes) is helpful in defining the duration of the anterograde effective refractory period of the accessory pathway." | 7.66 | Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome. ( Braat, S; Brugada, P; Dassen, WR; Gorgels, AP; Wellens, HJ, 1983) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 7.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 7.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 7.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "The effect of amiodarone in the Wolff-Parkinson-White syndrome was studied with programmed electrical stimulation of the heart in 15 patients." | 7.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. ( Bär, FW; Dohmen, HJ; Düren, DR; Durrer, D; Lie, KI; Wellens, HJ; Wesdorp, JC, 1976) |
| "When amiodarone treatment had become clinically effective, a second comparative study was made in four patients after 26--85 days' treatment." | 6.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study. ( Berning, J; Rasmussen, V, 1979) |
| "Nine had overt, and 6 had concealed WPW syndrome." | 5.30 | Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome. ( Kuga, K; Sugishita, Y; Yamaguchi, I, 1999) |
| "Propafenone was less effective (mean effect 3." | 5.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "Thus, the safety of amiodarone in the WPW syndrome should be established by electrophysiologic studies and induction of AF, because amiodarone is not protective in all patients with WPW." | 5.27 | Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. ( Fromer, MA; Kappenberger, LJ; Shenasa, M; Steinbrunn, W, 1984) |
| "Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 5.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 5.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 4.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "It was reported that intravenous amiodarone might induce ventricular fibrillation for acute treatment in patients with atrial fibrillation (AF) and Wolff-Parkinson-White (WPW) syndrome." | 4.02 | The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome. ( Ren, J; Shao, X; Wang, J; Wu, S; Yang, Y; Zhang, H; Zhu, J, 2021) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 3.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "Amiodarone-induced chemical, sterile epididymitis has previously been reported." | 3.69 | Amiodarone-induced epididymitis. Report of 2 cases. ( Hamoud, K; Kaneti, J; Lissmer, L; Smailowitz, Z, 1996) |
| "Amiodarone resulted in a rapid ventricular response to atrial flutter in an infant with Wolff-Parkinson-White syndrome." | 3.68 | Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome. ( Baxendall, M; Benetar, A; Till, JA, 1993) |
| "In a 20-year-old patient with Marfan's syndrome and Wolff-Parkinson-White syndrome, effective amiodarone treatment had to be stopped due to serious hyperthyroidism." | 3.67 | Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome. ( Hazenberg, HJ; Tietge, FC, 1985) |
| "In 12 patients (nine with Wolff-Parkinson-White syndrome and three with ventricular tachycardia) the electrophysiologic effects of intravenous (5 mg/kg body weight in 1 min) and oral (total dose 9800 to 11,200 mg) amiodarone were studied with programmed stimulation of the heart." | 3.67 | A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. ( Abdollah, H; Brugada, P; Dassen, WR; Wellens, HJ, 1984) |
| "The clinical and electrophysiologic effects of oral amiodarone were evaluated in 10 patients with a history of spontaneous atrial fibrillation and a rapid ventricular response, complicating the Wolff-Parkinson-White syndrome." | 3.67 | Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. ( Feld, GK; Klitzner, T; Nademanee, K; Singh, BN; Stevenson, W; Weiss, J, 1988) |
| "In order to control a re-entrant tachycardia in a patient with Wolff-Parkinson-White syndrome, intravenous Amiodarone (5 mg/Kg per min." | 3.67 | [Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Wolff-Parkinson-White syndrome]. ( Auricchio, A; De Stefano, R; Vitale, P, 1986) |
| "We observed a dangerous increase of ventricular rate following the intravenous administration of amiodarone in a patient with atrial fibrillation and rapid ventricular response associated with the Wolff-Parkinson-White syndrome." | 3.67 | Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. ( Gmeiner, R; Leisch, F; Schützenberger, W, 1987) |
| "This study was performed to ascertain whether intravenous amiodarone would revert supraventricular tachycardias to sinus rhythm, and if so, whether this effect depended upon the underlying mechanism of the arrhythmia." | 3.67 | Intravenous amiodarone in the acute termination of supraventricular arrhythmias. ( Crick, JC; Curry, P; Davies, DW; Holt, P, 1985) |
| "Amiodarone has proved to be a valuable drug in atrial fibrillation associated with the Wolff-Parkinson-White syndrome." | 3.66 | Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome. ( Evans, T; Sheinman, BD, 1982) |
| "An esophageal lead was used to perform decremental atrial pacing and elective induction of atrial fibrillation (AF) in 5 patients with the Wolff-Parkinson-White (W-P-W) syndrome before and after amiodarone therapy." | 3.66 | Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy. ( Coltorti, F; Condorelli, M; Critelli, G; Grassi, G; Monda, V; Perticone, F, 1983) |
| "A patient with types A and B of Wolff-Parkinson-White syndrome developed subacute pneumonitis during long-term treatment with amiodarone." | 3.66 | Subacute pneumopathy during amiodarone therapy. ( Bellotti, M; Bunster, AM; Elsner, B; Esteva, H; Poderoso, JJ; Suárez, LD, 1983) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 3.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "In patients with the Wolff-Parkinson-White syndrome, intravenous ajmaline (50 mg administered over 3 minutes) or procainamide (10 mg/kg body weight administered over 10 minutes) is helpful in defining the duration of the anterograde effective refractory period of the accessory pathway." | 3.66 | Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome. ( Braat, S; Brugada, P; Dassen, WR; Gorgels, AP; Wellens, HJ, 1983) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 3.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "Arrhythmias may be controlled in most patients with recurrent supraventricular tachycardia or atrial fibrillation with small to moderate maintenance doses of amiodarone (100 to 400 mg/day)." | 3.66 | Ten years of experience with amiodarone. ( Chiale, PA; Elizari, MV; Haedo, A; Lázzari, JO; Rosenbaum, MB, 1983) |
| "Oral amiodarone has been used to treat 21 patients with various supraventricular arrhythmias; 13 had Wolff-Parkinson-White syndrome, which was complicated by atrial fibrillation and re-entry atrioventricular tachycardia in four, and re-entry tachycardia alone in the other nine." | 3.66 | Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. ( Krikler, DM; Rowland, E, 1980) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 3.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "Oral amiodarone was administered to ten children aged 3 months to 15 years who had recurrent SVT associated with the Wolff-Parkinson-White syndrome." | 3.66 | Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. ( Barzilay, Z; Feigl, A; Frand, M; Shahar, E, 1983) |
| "The effect of amiodarone in the Wolff-Parkinson-White syndrome was studied with programmed electrical stimulation of the heart in 15 patients." | 3.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. ( Bär, FW; Dohmen, HJ; Düren, DR; Durrer, D; Lie, KI; Wellens, HJ; Wesdorp, JC, 1976) |
| "When amiodarone treatment had become clinically effective, a second comparative study was made in four patients after 26--85 days' treatment." | 2.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study. ( Berning, J; Rasmussen, V, 1979) |
| "Eight patients with WPW syndrome were catheterised and, during the course of this investigation, the electrophysiological effects of amiodarone were assessed." | 2.64 | [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome]. ( Delahaye, JP; Huerta, F; Porte, J; Touboul, P, 1976) |
| " Little justification for the use of agents or dosing in children is available." | 2.40 | Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. ( Kuhn, RJ; Luedtke, SA; McCaffrey, FM, 1997) |
| "Amiodarone has a reduced clearance rate, large volume of distribution, low bioavailability and a long half-life that may last 2 months in patients receiving short-term therapy." | 2.37 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1984) |
| "The management of ventricular tachycardia depends on clinical symptoms and is influenced by the presence of structural heart disease." | 1.37 | Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia? ( Kireyev, D; Lim, SL; Poh, KK; Teo, SG, 2011) |
| "Nine had overt, and 6 had concealed WPW syndrome." | 1.30 | Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome. ( Kuga, K; Sugishita, Y; Yamaguchi, I, 1999) |
| "Supraventricular tachycardia is one of the most frequent arrhythmias in childhood." | 1.27 | [Supraventricular tachycardia in children]. ( Attanà, A; Battaglia, T; Caristo, S; Ciconte, V; Fumarulo, A; Martini, B; Paparo, F, 1983) |
| "Association of long QT with arrhythmia does not, therefore, invalidate the principle that homogeneously prolonged APD should be anti-arrhythmic." | 1.27 | Delayed ventricular repolarization as an anti-arrhythmic principle. ( Vaughan Williams, EM, 1985) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 1.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "Thus, the safety of amiodarone in the WPW syndrome should be established by electrophysiologic studies and induction of AF, because amiodarone is not protective in all patients with WPW." | 1.27 | Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. ( Fromer, MA; Kappenberger, LJ; Shenasa, M; Steinbrunn, W, 1984) |
| "Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 1.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
| "Verapamil was more effective due to the immediate response and lack of adverse effects." | 1.27 | Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone. ( Barzilay, Z; Frand, M; Shahar, E; Shem-Tov, AA; Shohet, I, 1983) |
| "Propafenone was less effective (mean effect 3." | 1.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "Type 2 tachycardia was of the slow-fast A-V nodal pathway type." | 1.26 | Quintuple pathways participating in three distinct types of atrioventricular reciprocating tachycardia in a patient with Wolff-Parkinson-White syndrome. ( Castellanos, A; Portillo, B; Portillo-Leon, N; Zaman, L, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 67 (74.44) | 18.7374 |
| 1990's | 12 (13.33) | 18.2507 |
| 2000's | 4 (4.44) | 29.6817 |
| 2010's | 6 (6.67) | 24.3611 |
| 2020's | 1 (1.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, J | 1 |
| Yang, Y | 1 |
| Zhu, J | 1 |
| Wu, S | 1 |
| Wang, J | 1 |
| Zhang, H | 1 |
| Shao, X | 1 |
| Cadrin-Tourigny, J | 1 |
| Fournier, A | 1 |
| Andelfinger, G | 1 |
| Khairy, P | 1 |
| Bodalski, R | 1 |
| Maryniak, A | 1 |
| Walczak, F | 1 |
| Szumowski, L | 1 |
| Jedynak, Z | 1 |
| Simonian, SM | 1 |
| Lotfipour, S | 1 |
| Wall, C | 1 |
| Langdorf, MI | 1 |
| Maheshwari, M | 1 |
| Mittal, SR | 1 |
| Brace, S | 1 |
| Lim, SL | 1 |
| Teo, SG | 1 |
| Kireyev, D | 1 |
| Poh, KK | 1 |
| Trombert, V | 1 |
| Samaras, N | 1 |
| Willich, T | 1 |
| Hammwöhner, M | 1 |
| Goette, A | 1 |
| Ozaydín, M | 1 |
| Varol, E | 1 |
| Dogan, A | 1 |
| Aslan, SM | 1 |
| Altínbas, A | 1 |
| Negro, R | 1 |
| Aloisi, B | 1 |
| Russo, L | 1 |
| Mazzaglia, G | 1 |
| Liistro, M | 1 |
| Brancati, B | 1 |
| Prystowsky, EN | 2 |
| Coumel, P | 2 |
| Leclercq, JF | 1 |
| Assayag, P | 1 |
| Zipes, DP | 2 |
| Heger, JJ | 1 |
| Kappenberger, LJ | 1 |
| Fromer, MA | 1 |
| Steinbrunn, W | 1 |
| Shenasa, M | 1 |
| Vergara de Campos, A | 1 |
| Otero Chulián, E | 1 |
| González Martínez, V | 1 |
| Cardenete Ibañez, F | 1 |
| Rico Irles, J | 1 |
| Dick, M | 1 |
| Campbell, RM | 1 |
| Johns, JA | 1 |
| Harper, RW | 1 |
| Currie, PJ | 1 |
| Federman, J | 1 |
| Anderson, ST | 1 |
| Pitt, A | 1 |
| Wellens, HJ | 8 |
| Brugada, P | 6 |
| Abdollah, H | 2 |
| Rosenbaum, MB | 4 |
| Chiale, PA | 4 |
| Haedo, A | 1 |
| Lázzari, JO | 2 |
| Elizari, MV | 4 |
| Shahar, E | 2 |
| Barzilay, Z | 2 |
| Frand, M | 2 |
| Feigl, A | 1 |
| Hesslein, PS | 1 |
| Battaglia, T | 1 |
| Paparo, F | 1 |
| Fumarulo, A | 1 |
| Attanà, A | 1 |
| Ciconte, V | 1 |
| Caristo, S | 1 |
| Martini, B | 1 |
| Dassen, WR | 3 |
| Feld, GK | 2 |
| Nademanee, K | 2 |
| Weiss, J | 2 |
| Stevenson, W | 2 |
| Singh, BN | 2 |
| Heddle, WF | 1 |
| Garabedian, V | 1 |
| Lagarde, O | 1 |
| Guiraudon, C | 1 |
| Frank, F | 1 |
| Fontaine, G | 1 |
| Richart, JC | 1 |
| Coignard, A | 1 |
| Duret, JC | 1 |
| Mardelle, T | 1 |
| Droniou, J | 1 |
| Sheinman, BD | 1 |
| Evans, T | 1 |
| Critelli, G | 1 |
| Grassi, G | 1 |
| Perticone, F | 3 |
| Coltorti, F | 1 |
| Monda, V | 2 |
| Condorelli, M | 1 |
| Suárez, LD | 1 |
| Poderoso, JJ | 1 |
| Elsner, B | 1 |
| Bunster, AM | 1 |
| Esteva, H | 1 |
| Bellotti, M | 1 |
| Shem-Tov, AA | 1 |
| Shohet, I | 1 |
| Braat, S | 1 |
| Gorgels, AP | 1 |
| Lubbe, WF | 1 |
| Mercer, CJ | 1 |
| Roche, AH | 1 |
| Lowe, JB | 1 |
| Marcus, FI | 1 |
| Fontaine, GH | 1 |
| Frank, R | 1 |
| Grosgogeat, Y | 1 |
| Lukoshevichiute, AI | 1 |
| Reĭngardene, DI | 1 |
| Portillo, B | 1 |
| Portillo-Leon, N | 1 |
| Zaman, L | 1 |
| Castellanos, A | 1 |
| Podrid, PJ | 1 |
| Lown, B | 1 |
| Przybylski, J | 3 |
| Halpern, MS | 2 |
| Nau, GJ | 1 |
| Bär, FW | 2 |
| Vanagt, EJ | 1 |
| Farré, J | 1 |
| Rowland, E | 2 |
| Krikler, DM | 2 |
| Ward, DE | 1 |
| Camm, AJ | 1 |
| Spurrell, RA | 1 |
| Chia, BL | 1 |
| Teo, WS | 1 |
| Agnant, RA | 1 |
| Louis, R | 1 |
| Bury, T | 1 |
| Radermecker, MF | 1 |
| Moro Serrano, C | 1 |
| Hernández Madrid, A | 1 |
| Lage Silveira, J | 1 |
| Vivas Alvarez, E | 1 |
| Kanjhi, M | 1 |
| De Catte, L | 1 |
| De Wolf, D | 2 |
| Smitz, J | 2 |
| Bougatef, A | 1 |
| De Schepper, J | 2 |
| Foulon, W | 1 |
| Till, JA | 1 |
| Baxendall, M | 1 |
| Benetar, A | 1 |
| Chen, SA | 1 |
| Chiang, CE | 1 |
| Tai, CT | 1 |
| Lee, SH | 1 |
| Chiou, CW | 1 |
| Ueng, KC | 1 |
| Wen, ZC | 1 |
| Cheng, CC | 1 |
| Chang, MS | 1 |
| Boriani, G | 1 |
| Biffi, M | 1 |
| Frabetti, L | 1 |
| Azzolini, U | 1 |
| Sabbatani, P | 1 |
| Bronzetti, G | 1 |
| Capucci, A | 1 |
| Magnani, B | 1 |
| Hamoud, K | 1 |
| Kaneti, J | 1 |
| Smailowitz, Z | 1 |
| Lissmer, L | 1 |
| Luedtke, SA | 1 |
| Kuhn, RJ | 1 |
| McCaffrey, FM | 1 |
| Gómez-Barrado, JJ | 1 |
| García-Rubira, JC | 1 |
| Turégano Albarrán, S | 1 |
| Pavón García, M | 1 |
| Hidalgo Urbano, R | 1 |
| Montes Ramírez, JM | 1 |
| Cruz Fernández, JM | 1 |
| Matiushin, GV | 1 |
| Shul'man, VA | 1 |
| Balog, AI | 1 |
| Golovenkin, SE | 1 |
| Bezruk, AP | 1 |
| Ivanitskiĭ, EA | 1 |
| Smirnova, OV | 1 |
| Kuga, K | 1 |
| Yamaguchi, I | 1 |
| Sugishita, Y | 1 |
| Trohman, RG | 1 |
| Preobrazhenskiĭ, DV | 1 |
| Ryndina, MG | 1 |
| Blizniak, GV | 1 |
| Curry, PV | 1 |
| Krikler, D | 1 |
| Rosen, MR | 1 |
| Waleffe, A | 1 |
| Bruninx, P | 1 |
| Kulbertus, HE | 1 |
| Rasmussen, V | 1 |
| Berning, J | 1 |
| Cosma, C | 1 |
| Crepin, D | 1 |
| Py, J | 1 |
| Bennett, DH | 1 |
| Gribbin, B | 1 |
| Birkhead, JS | 1 |
| Chamberlain, DA | 1 |
| Clark, AN | 1 |
| Barbosa Lopes, AA | 1 |
| Scalabrini Neto, A | 1 |
| Barbosa, SA | 1 |
| Tranchesi, J | 1 |
| Gronda, M | 1 |
| Rognoni, G | 1 |
| Rossi, P | 1 |
| Touboul, P | 1 |
| Porte, J | 1 |
| Huerta, F | 1 |
| Delahaye, JP | 1 |
| Lie, KI | 1 |
| Wesdorp, JC | 1 |
| Dohmen, HJ | 1 |
| Düren, DR | 1 |
| Durrer, D | 1 |
| Quinteiro, RA | 1 |
| Vaughan Williams, EM | 1 |
| Tuzcu, EM | 1 |
| Gilbo, J | 1 |
| Masterson, M | 1 |
| Maloney, JD | 1 |
| Casciani, M | 1 |
| Podestà, M | 1 |
| Carolis, S | 1 |
| Bargellini, F | 1 |
| Anticoli Borza, S | 1 |
| Dewachter, A | 1 |
| Lievens, H | 1 |
| Klitzner, T | 1 |
| Verhaaren, H | 1 |
| Deneyer, M | 1 |
| Sacre-Smits, L | 1 |
| Depelchin, P | 1 |
| Schoenfeld, P | 1 |
| Stoupel, E | 1 |
| Degré, S | 1 |
| Vitale, P | 1 |
| De Stefano, R | 1 |
| Auricchio, A | 1 |
| Shepherd, NA | 1 |
| Dawson, AM | 1 |
| Crocker, PR | 1 |
| Levison, DA | 1 |
| Schützenberger, W | 1 |
| Leisch, F | 1 |
| Gmeiner, R | 1 |
| Cuda, G | 1 |
| Spadea, F | 2 |
| Pintaudi, C | 2 |
| Tropea, R | 2 |
| Adinolfi, L | 1 |
| Golia, B | 1 |
| Montano, A | 1 |
| Romano, M | 1 |
| Maione, S | 1 |
| Chiacchio, T | 1 |
| Mazza, F | 1 |
| Columbro, C | 1 |
| Bova, G | 1 |
| Jaeger, M | 1 |
| Santos, MA | 1 |
| Simões, LC | 1 |
| Liu, PH | 1 |
| Lin, CC | 1 |
| Ko, GC | 1 |
| Wang, DJ | 1 |
| Shieh, SM | 1 |
| Sung, PK | 1 |
| Gonzalez, MD | 1 |
| Guillen, RH | 1 |
| Pellizzon, OA | 1 |
| Raimondi, EC | 1 |
| Holt, P | 1 |
| Crick, JC | 1 |
| Davies, DW | 1 |
| Curry, P | 1 |
| Penn, IM | 1 |
| Barrett, PA | 1 |
| Pannikote, V | 1 |
| Barnaby, PF | 1 |
| Campbell, JB | 1 |
| Lyons, NR | 1 |
| Hazenberg, HJ | 1 |
| Tietge, FC | 1 |
| Yagupsky, P | 1 |
| Gazala, E | 1 |
| Sofer, S | 1 |
| Maor, E | 1 |
| Abarbanel, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for amiodarone and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Emergency Servi | 2010 |
[Therapy of atrial fibrillation in the critically ill].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Comorbidity; Contraindicati | 2012 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atr | 1983 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atria | 1981 |
[Value of drug tests in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electr | 1981 |
[Amiodarone in the nineties: to whom and what dosage?].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Clinical Trials | 1995 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Ch | 1997 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiogra | 2000 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
[Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; H | 1986 |
3 trials available for amiodarone and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study.
Topics: Adult; Aged; Amiodarone; Benzofurans; Bundle of His; Cardiac Pacing, Artificial; Clinical Trials as | 1979 |
[Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
Topics: Action Potentials; Adult; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Bundle of His; Clinical T | 1976 |
77 other studies available for amiodarone and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Infusions, Intravenous; Mal | 2021 |
Severe left ventricular dysfunction in infants with ventricular preexcitation.
Topics: Adrenergic alpha-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilate | 2008 |
[Glass of water or ablation? - episodes of malignant atrial tachyarrhythmias during swimming in a lake in a woman with overt Wolff-Parkinson-White syndrome and benign palpitations for several decades of life].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter | 2008 |
Wolff-Parkinson-White syndrome and rheumatic mitral stenosis--an uncommon association.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Diuretics; Electrocardiography; Humans; Male; Mi | 2010 |
Emergency treatment of Wolff-Parkinson-White syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Causality; Electric Countershock; Electrocardiography; Emergency | 2011 |
Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia?
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiology; Diagnosis, D | 2011 |
[Practical problem on ECG in elderly patient. Case #18].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; | 2011 |
Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Dopamine; Drug Therapy, | 2007 |
[Long-term use of amiodarone in the treatment of ventricular pre-excitation with tachyarrhythmia attacks].
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Benzofurans; Drug Therapy, Combination; Humans; Q | 1981 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1984 |
Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Electro | 1984 |
[Electrophysiologic study of pre-excitation syndromes in our environment (V)].
Topics: Amiodarone; Cardiac Catheterization; Electrocardiography; Heart Conduction System; Humans; Wolff-Par | 1984 |
Advances in the management of cardiac arrhythmias in children.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pa | 1984 |
Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Kinetics; Ma | 1983 |
Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
Topics: Ajmaline; Amiodarone; Atrial Fibrillation; Benzofurans; Electrophysiology; Heart; Humans; Isoprotere | 1983 |
Ten years of experience with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Chagas Cardiomyopathy; Dose-Resp | 1983 |
Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Adolescent; Amiodarone; Benzofurans; Child; Child, Preschool; Electrocardiogra | 1983 |
Amiodarone therapy in children: a cautionary comment.
Topics: Adolescent; Amiodarone; Benzofurans; Child; Child, Preschool; Humans; Infant; Tachycardia; Wolff-Par | 1983 |
[Supraventricular tachycardia in children].
Topics: Adenosine Triphosphate; Amiodarone; Cardiac Pacing, Artificial; Child; Digitalis Glycosides; Heart D | 1983 |
A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Child; | 1984 |
Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
Topics: Adult; Aged; Amiodarone; Benzofurans; Digoxin; Electrocardiography; Heart Conduction System; Humans; | 1984 |
Multiple circus movement tachycardias with multiple accessory pathways.
Topics: Amiodarone; Atrioventricular Node; Cardiac Pacing, Artificial; Child; Electrocardiography; Female; H | 1984 |
[Malignant ventricular tachyarrythmia due to atrial fibrillation in the Wolff-Parkinson-White syndrome. Section of the Kent bundle apropos of 2 cases].
Topics: Adult; Amiodarone; Atrial Fibrillation; Electrocardiography; Electrophysiology; Heart Conduction Sys | 1981 |
Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
Topics: Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Humans; Male; Tachycardia; | 1982 |
Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Cardiac Pacing, Artificial; Death, Sudden; Esoph | 1983 |
Subacute pneumopathy during amiodarone therapy.
Topics: Amiodarone; Benzofurans; Female; Humans; Lung; Middle Aged; Pneumonia; Wolff-Parkinson-White Syndrom | 1983 |
Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone.
Topics: Adolescent; Amiodarone; Child; Child, Preschool; Digoxin; Electrocardiography; Humans; Infant; Infan | 1983 |
Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Benzofurans; Electrophysiology; Female; Heart Conduction Sy | 1983 |
Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Female; Heart Atria | 1981 |
Quintuple pathways participating in three distinct types of atrioventricular reciprocating tachycardia in a patient with Wolff-Parkinson-White syndrome.
Topics: Aged; Amiodarone; Atrioventricular Node; Electrocardiography; Electrophysiology; Heart Conduction Sy | 1982 |
Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle | 1981 |
Unmasking of ventricular preexcitation by vagal stimulation or isoproterenol administration.
Topics: Adult; Ajmaline; Amiodarone; Female; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Mal | 1980 |
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
Topics: Accessory Nerve; Adolescent; Adult; Ajmaline; Amiodarone; Child; Female; Heart Block; Humans; Male; | 1980 |
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Ele | 1980 |
Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Child; Drug Administration Sc | 1980 |
Right praecordial early repolarization pattern occurring with the Wolff-Parkinson-White pattern.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Heart Conduction System; Humans; Male; Midd | 1995 |
[Clinical case of the month. Apropos of a case of amiodarone-induced lung disease].
Topics: Amiodarone; Humans; Male; Middle Aged; Pulmonary Fibrosis; Tomography, X-Ray Computed; Wolff-Parkins | 1995 |
Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Male; P | 1994 |
Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome.
Topics: Amiodarone; Atrial Flutter; Heart; Humans; Infant, Newborn; Male; Wolff-Parkinson-White Syndrome | 1993 |
Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular N | 1996 |
Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Male | 1996 |
Amiodarone-induced epididymitis. Report of 2 cases.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epididymitis; Humans; Male; Middle | 1996 |
[Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Heart Arrest; Humans; Middle | 1997 |
[Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Administration Schedule; | 1998 |
Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Conduction System; Humans | 1999 |
Dual-demand pacing for refractory atrioventricular re-entry tachycardia.
Topics: Adult; Amiodarone; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Heart Ve | 1979 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Ca | 1978 |
Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Cardia | 1978 |
[Action and adverse effects of amiodarone in Wolff-Parkinson-White syndrome].
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Female; Heart Rate; Humans; Tachycardia, Paroxysmal; Wol | 1979 |
Identical twins with differing forms of ventricular pre-excitation.
Topics: Amiodarone; Child; Diseases in Twins; Electrocardiography; Female; Heart; Heart Conduction System; H | 1978 |
Atrial fibrillation complicating Wolff-Parkinson-White syndrome treated with amiodarone.
Topics: Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Humans; Male; Wolff-Parkins | 1977 |
Existence of automaticity in anomalous bundle of Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Electrocardiography; Female; Heart Conduction System; Human | 1978 |
[Wolff-Parkinson-White syndrome associated with morphology of complete left bundle branch block in a person with patent ductus arteriosus].
Topics: Amiodarone; Bundle of His; Bundle-Branch Block; Ductus Arteriosus, Patent; Electrocardiography; Hear | 1978 |
[The control of the atrio-ventricular reciprocating tachyarrhythmias. A preliminary electrophysiological study and comparison between amiodarone and verapamil (author's transl)].
Topics: Adult; Aged; Amiodarone; Benzofurans; Drug Evaluation; Female; Humans; Male; Middle Aged; Tachycardi | 1978 |
Effect of amiodarone in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Electrocardi | 1976 |
The occurrence of phase-4 block in the anomalous bundle of patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Electrocardiography; Female; Heart Conduction System; Heart | 1975 |
Delayed ventricular repolarization as an anti-arrhythmic principle.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bund | 1985 |
The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Chronic Disease; Female; Humans; Ma | 1989 |
[Wolff-Parkinson-White syndrome and anesthesia].
Topics: Adult; Amiodarone; Anesthesia, General; Female; Flecainide; Humans; Propranolol; Tachycardia, Paroxy | 1987 |
Amiodarone and optic neuropathy.
Topics: Amiodarone; Female; Fluorescein Angiography; Humans; Male; Middle Aged; Optic Nerve Diseases; Vision | 1988 |
Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
Topics: Adult; Amiodarone; Atrial Fibrillation; Child; Electrophysiology; Female; Heart Atria; Heart Conduct | 1988 |
Congenital hypothyroid goiter and amiodarone.
Topics: Adult; Amiodarone; Congenital Hypothyroidism; Female; Goiter; Humans; Hypothyroidism; Infant; Infant | 1988 |
[Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Wolff-Parkinson-White syndrome].
Topics: Adult; Amiodarone; Electrocardiography; Female; Humans; Injections, Intravenous; Tachycardia, Paroxy | 1986 |
Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.
Topics: Amiodarone; Chemical and Drug Induced Liver Injury; Cytoplasmic Granules; Female; Humans; Iodine; Li | 1987 |
Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report.
Topics: Amiodarone; Atrial Fibrillation; Female; Heart Conduction System; Heart Rate; Humans; Middle Aged; W | 1987 |
Malignant ventricular arrhythmia in the Wolff-Parkinson-White syndrome during amiodarone treatment.
Topics: Adult; Amiodarone; Atrioventricular Node; Cardiac Pacing, Artificial; Electrophysiology; Heart Condu | 1987 |
Amiodarone treatment in cardiac preexcitation syndrome: use of signal averaged electrocardiogram.
Topics: Adolescent; Adult; Amiodarone; Electrocardiography; Humans; Middle Aged; Wolff-Parkinson-White Syndr | 1987 |
[Importance of retrograde occult conduction on the modulation of the ventricular response in the cardiac pre-excitation syndrome].
Topics: Adult; Amiodarone; Electric Countershock; Electric Stimulation; Heart Conduction System; Humans; Mal | 1987 |
[How should we treat the Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Aged; Amiodarone; Cryosurgery; Digitalis Glycosides; Electrocardiography; Electro | 1986 |
Paroxysmal supraventricular tachycardia in supero-inferior ventricles with intact ventricular septum.
Topics: Amiodarone; Electrocardiography; Female; Heart; Humans; Infant; Radiography; Tachycardia, Paroxysmal | 1987 |
Electrophysiologic effects of amiodarone in tachyarrhythmias.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Female; Heart; Humans; Mal | 1985 |
Study of Wolff-Parkinson-White syndrome by transesophageal pacing and assessment of long-term amiodarone therapy.
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography; E | 1985 |
Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Cardia | 1985 |
Amiodarone in pregnancy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Female; Fetal Blood; Human | 1985 |
Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome.
Topics: Adult; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Marfan Syndrome; Thyroid Function T | 1985 |
Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrophysiology; Heart | 1985 |
Fatal hepatic failure and encephalopathy associated with amiodarone therapy.
Topics: Amiodarone; Benzofurans; Biopsy; Child; Female; Hepatic Encephalopathy; Humans; Liver; Reye Syndrome | 1985 |